Author | Scott Gettinger, MD | OncLive

Author | Scott Gettinger, MD


Dr. Gettinger on Lung Cancer Immunotherapies

January 08, 2013


Scott Gettinger, MD, associate professor of medicine (medical oncology), Yale School of Medicine, explains the development of immunotherapies in lung cancer.

Dr. Gettinger on PD-1 Inhibitor BMS-936558 in NSCLC

December 11, 2012


Scott Gettinger, MD, from the Yale School of Medicine, discusses updated results from a phase I trial that examined the novel immunotherapy BMS-936558 in patients with NSCLC and other solid tumors.